Nanalysis Scientific Corp. (FRA:1N1)

Market Cap	13.32M -47.1%
Revenue (ttm)	25.54M -2.9%
Net Income	-7.58M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0935
Previous Close	0.0970
Day's Range	0.0935 - 0.0935
52-Week Range	0.0775 - 0.2160
Beta	n/a
RSI	46.63
Earnings Date	Apr 24, 2026

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides softwa...

• Industry: Electromedical and Electrotherapeutic Apparatus
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1N1

Financial Performance

In 2024, Nanalysis Scientific's revenue was 45.50 million, an increase of 59.82% compared to the previous year's 28.47 million. Losses were -13.61 million, -15.95% less than in 2023.

Financial numbers in CAD